294 related articles for article (PubMed ID: 15044029)
1. Contributions of 5-HT(2C) receptors to multiple actions of central serotonin systems.
Giorgetti M; Tecott LH
Eur J Pharmacol; 2004 Mar; 488(1-3):1-9. PubMed ID: 15044029
[TBL] [Abstract][Full Text] [Related]
2. Role of serotonin and dopamine receptor binding in antipsychotic efficacy.
Richtand NM; Welge JA; Logue AD; Keck PE; Strakowski SM; McNamara RK
Prog Brain Res; 2008; 172():155-75. PubMed ID: 18772032
[TBL] [Abstract][Full Text] [Related]
3. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
Bubar MJ; Cunningham KA
Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
[TBL] [Abstract][Full Text] [Related]
4. Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies.
Di Matteo V; Di Giovanni G; Pierucci M; Esposito E
Prog Brain Res; 2008; 172():7-44. PubMed ID: 18772026
[TBL] [Abstract][Full Text] [Related]
5. Physiological and therapeutic relevance of constitutive activity of 5-HT 2A and 5-HT 2C receptors for the treatment of depression.
Berg KA; Harvey JA; Spampinato U; Clarke WP
Prog Brain Res; 2008; 172():287-305. PubMed ID: 18772038
[TBL] [Abstract][Full Text] [Related]
6. Effect of chronic treatment with clozapine and haloperidol on 5-HT(2A and 2C) receptor mRNA expression in the rat brain.
Huang XF; Tan YY; Huang X; Wang Q
Neurosci Res; 2007 Nov; 59(3):314-21. PubMed ID: 17868938
[TBL] [Abstract][Full Text] [Related]
7. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
Broderick PA; Olabisi OA; Rahni DN; Zhou Y
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 5-hydroxytryptamine2C receptor signaling in hypothalamic proopiomelanocortin neurons: role in energy homeostasis in females.
Qiu J; Xue C; Bosch MA; Murphy JG; Fan W; Rønnekleiv OK; Kelly MJ
Mol Pharmacol; 2007 Oct; 72(4):885-96. PubMed ID: 17622577
[TBL] [Abstract][Full Text] [Related]
9. Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone.
Harada K; Aota M; Inoue T; Matsuda R; Mihara T; Yamaji T; Ishibashi K; Matsuoka N
Eur J Pharmacol; 2006 Dec; 553(1-3):171-84. PubMed ID: 17074317
[TBL] [Abstract][Full Text] [Related]
10. Region-dependent regulation of mesoaccumbens dopamine neurons in vivo by the constitutive activity of central serotonin2C receptors.
Navailles S; Moison D; Ryczko D; Spampinato U
J Neurochem; 2006 Nov; 99(4):1311-9. PubMed ID: 17018023
[TBL] [Abstract][Full Text] [Related]
11. 5-HT(2C) receptor activation inhibits appetitive and consummatory components of feeding and increases brain c-fos immunoreactivity in mice.
Somerville EM; Horwood JM; Lee MD; Kennett GA; Clifton PG
Eur J Neurosci; 2007 May; 25(10):3115-24. PubMed ID: 17561825
[TBL] [Abstract][Full Text] [Related]
12. Affinity of cyamemazine metabolites for serotonin, histamine and dopamine receptor subtypes.
Benyamina A; Arbus C; Nuss P; Garay RP; Neliat G; Hameg A
Eur J Pharmacol; 2008 Jan; 578(2-3):142-7. PubMed ID: 17936750
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of JL 13, a potential atypical antipsychotic, on rat dopamine and serotonin receptor subtypes.
Moran-Gates T; Massari C; Graulich A; Liégeois JF; Tarazi FI
J Neurosci Res; 2006 Aug; 84(3):675-82. PubMed ID: 16810690
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of 5-HT(2A) and 5-HT(2C) receptor mRNAs in mice prone, or resistant, to chronic high-fat diet-induced obesity.
Huang XF; Han M; Storlien LH
Brain Res Mol Brain Res; 2004 Aug; 127(1-2):39-47. PubMed ID: 15306119
[TBL] [Abstract][Full Text] [Related]
15. In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems.
Meltzer HY; Huang M
Prog Brain Res; 2008; 172():177-97. PubMed ID: 18772033
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
17. Studies on the neuroendocrine role of serotonin.
Jørgensen HS
Dan Med Bull; 2007 Nov; 54(4):266-88. PubMed ID: 18208678
[TBL] [Abstract][Full Text] [Related]
18. Modulation of dopamine release by striatal 5-HT2C receptors.
Alex KD; Yavanian GJ; McFarlane HG; Pluto CP; Pehek EA
Synapse; 2005 Mar; 55(4):242-51. PubMed ID: 15668911
[TBL] [Abstract][Full Text] [Related]
19. Intracellular 5-HT 2C-receptor dephosphorylation: a new target for treating drug addiction.
Müller CP; Carey RJ
Trends Pharmacol Sci; 2006 Sep; 27(9):455-8. PubMed ID: 16876260
[TBL] [Abstract][Full Text] [Related]
20. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors.
Wang R; Xu Y; Wu HL; Li YB; Li YH; Guo JB; Li XJ
Eur J Pharmacol; 2008 Jan; 578(1):43-50. PubMed ID: 17942093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
